What is the global market size of Hemostatic Agents Market?

Global Hemostatic Agents Market size was valued at USD 6.13 billion in 2021 and is poised to grow from USD 7.38 billion in 2022 to USD 14.48 billion by 2030, growing at a CAGR of 8.8% in the forecast period (2023-2030).

Global Hemostatic Agents Market Size, Share, Growth Analysis, By Product(Active, passive), By Application(Trauma, cardiovascular surgery), By Type(Thrombin Based Hemostats, Gelatin Based Hemostats), By End User(Hospitals, Surgery Centers) - Industry Forecast 2024-2031

Report ID: SQMIG35B2068 | Region: Global | Published Date: February, 2024
Pages: 242 | Tables: 127 | Figures: 81

Global Hemostatic Agents Market Insights

Hemostatic Agents Market size was valued at USD 6.13 billion in 2019 and is poised to grow from USD 7.38 billion in 2023 to USD 14.48 billion by 2031, growing at a CAGR of 8.8% in the forecast period (2024-2031).

The growing number of patients with bleeding issues needs the adoption of technologically advanced hemostasis medicines. The increasing frequency of chronic diseases in the senior population is pushing increased demand for hemostasis agents. Because of the increase in surgical procedures around the world, there will be a high need for hemostasis agents, which will fuel market expansion. According to the World Health Organization (WHO), over 1.25 million people are injured in road accidents each year, with many deaths resulting in severe bleeding, fueling the market. Furthermore, developments in surgical techniques such as robot assisted surgery, as well as an ageing population, are likely to increase demand in the global Hemostatic Agents Market.

The high cost of surgical treatments, along with unfavorable reimbursement policies, may limit the market growth. Also, a lack of understanding and awareness about the most recent technological breakthroughs in emerging and undeveloped nations may limit the growth of the Hemostatic Agents market.

US Hemostatic Agents Market is poised to grow at a sustainable CAGR for the next forecast year.

Global Hemostatic Agents Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Hemostatic Agents Market is fragmented and highly competitive. Key industry players are focused on product developments, new product launches, and geographical expansions to gain a significant amount of market share. 'Baxter International Inc.', 'Pfizer Inc.', 'Ethicon, Inc. (a subsidiary of Johnson & Johnson)', 'CSL Behring', 'CryoLife, Inc.', 'Integra LifeSciences Holdings Corporation', 'B. Braun Melsungen AG', 'Z-Medica LLC', 'Marine Polymer Technologies, Inc.', 'Hemostasis, LLC', 'Cohera Medical, Inc.', 'ProFibrix BV', 'Starch Medical Inc.', 'Biom'Up SAS', 'MedTrade Products Ltd.', 'Vascular Solutions, Inc. (a subsidiary of Teleflex Incorporated)', 'Gelita Medical GmbH', 'Equimedical B.V.', 'Anika Therapeutics, Inc.', 'Arch Therapeutics, Inc.', 'In October 2022, Creilson, Inc., a Brooklyn-based biotechnology company, announced the successful execution of a USD 25 million Series A-4 fundraising round led by Paulson Investment Company to speed the introduction of its revolutionary hemostatic gel, VETIGEL, into the human health market following the filing of a 510(k) premarket notification to the US Food and Drug Administration.', 'In July 2021, Baxter International Inc. invested up to USD 60.8 million for certain assets of CryoLife's PerClot Polysaccharide Hemostatic System.', 'In February 2021, EndoClot Plus, Inc. stated that the US Food and Drug Administration had approved the EndoClot Polysaccharide Hemostatic System (FDA). This revolutionary tool assists gastroenterologists in quickly preventing bleeding. This technology marks a huge step forward in the treatment of G.I. patients.', 'In July 2021, Medcura, Inc., a medical device business, and ASO LLC announced the debut of Rapid-Seal, a new class of antibacterial hemostatic gel. This product satisfies the market requirement for a clear gel that may be simply applied to injuries.'

The spike in the number of surgical procedures performed globally has provided the impetus to offer a major boost to the rising incidence of bleeding issues during surgeries, which is the most crucial driving force of the global market. In the contemporary scenario, there is a wide range of medical devices available for care, as well as a considerable advance in the attainment of hemostasis in surgical procedures. According to recent estimates provided by the National Center for Biotechnology Information (NCBI), around 60-70% of all transfused red blood cells are used in a surgical context, as bleeding during surgery is one of the most feared problems that might occur during these procedures. This has resulted in a significant demand for the product offerings in the global market, as many surgeons prefer to use these goods in surgical operations with a low risk of bleeding issues.

The leading cause of military and civilian mortality is hemorrhage. The uncontrolled hemorrhage causes more than 30% of traumatic deaths in emergency conditions, and excessive bleeding is the leading cause of military casualties. Hemostatic drugs have been shown to be useful in hospitals and to save lives in high-stress situations. This will drive the hemostats market forward. The agents save lives by preventing hypothermia, infections, multiple organ failure, and acidosis. It is a critical stage in trauma treatment.

North America dominated the global hemostatic agent market. Some of the elements contributing to the dominance include the use of technologically sophisticated products and rising surgical operation numbers, which result in increased demand for the product.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Global Hemostatic Agents Market Size, Share, Growth Analysis, By Product(Active, passive), By Application(Trauma, cardiovascular surgery), By Type(Thrombin Based Hemostats, Gelatin Based Hemostats), By End User(Hospitals, Surgery Centers) - Industry Forecast 2024-2031

Global Hemostatic Agents Market Insights

Global Hemostatic Agents Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Hemostatic Agents Market?

Who are the key vendors in the Global Hemostatic Agents Market?

What is the key driver of Global Hemostatic Agents Market?

What is the key market trend for Global Hemostatic Agents Market?

Which region accounted for the largest share in Global Hemostatic Agents Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300